Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China
· Delayed Price · Currency is CNY 16.68
-0.13 (-0.77%)
Apr 30, 2026, 12:55 PM CST
SHE:002393 Revenue
Tianjin Lisheng Pharmaceutical had revenue of 332.28M CNY in the quarter ending March 31, 2026, a decrease of -10.16%. This brings the company's revenue in the last twelve months to 1.35B, up 0.99% year-over-year. In the year 2025, Tianjin Lisheng Pharmaceutical had annual revenue of 1.39B with 4.18% growth.
Revenue (ttm)
1.35B
Revenue Growth
+0.99%
P/S Ratio
3.82
Revenue / Employee
843.90K
Employees
1,605
Market Cap
5.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.39B | 55.86M | 4.18% |
| Dec 31, 2024 | 1.34B | 183.12M | 15.88% |
| Dec 31, 2023 | 1.15B | 6.44M | 0.56% |
| Jan 1, 2023 | 1.15B | 54.65M | 5.00% |
| Jan 1, 2022 | 1.09B | -48.90M | -4.29% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Science Sun Pharmaceutical | 404.72M |
| HPGC Renmintongtai Pharmaceutical | 10.54B |
| Luoxin Pharmaceuticals Group Stock | 2.37B |
| Jiangsu Jibeier Pharmaceutical | 964.93M |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.68B |
| Zhongzhu Healthcare Holding Co.,Ltd | 577.34M |
| Chongqing Pharscin Pharmaceutical | 827.14M |
| Beijing Beilu Pharmaceutical | 1.21B |